BioSpace News Archive

Press Releases

AAVantgarde Completes Enrollment in LUCE-1 Phase 1/2 Clinical Trial of AAVB-081 for Usher Syndrome Type B-associated Retinitis Pigmentosa

January 16, 2026
·
4 min read
Press Releases

Axsome Therapeutics Initiates FORWARD Phase 3 Trial of AXS-14 for the Management of Fibromyalgia

January 16, 2026
·
6 min read
Press Releases

Abpro’s Lead Program ABP-102 Featured in Celltrion Presentation at the 44th Annual J.P. Morgan Healthcare Conference

January 16, 2026
·
5 min read
Press Releases

Boston Scientific announces agreement to acquire Penumbra, Inc.

January 16, 2026
·
15 min read
Press Releases

Elevate Healthcare Marketing Appoints Industry Veteran Karen Beckert as Executive Vice President, Client Engagement and Customer Activation

January 16, 2026
·
3 min read
Press Releases

Penumbra, Inc. Provides Preliminary Update on Fourth Quarter and Full Year 2025 Financial Results

January 16, 2026
·
1 min read
Press Releases

Brenig Therapeutics Announces Initiation of First-in-Human Study of BT-409, a Brain-Selective NLRP3 Inhibitor, and Provides Update on BT-267, its LRRK2 Program

January 16, 2026
·
4 min read
Press Releases

IDEXX Advances the Future of Veterinary Cancer Care with Comprehensive Mast Cell Tumor Testing for Dogs

January 16, 2026
·
6 min read
Press Releases

Agenus Announces Closing of $141M Strategic Collaboration with Zydus Lifesciences to Advance BOT+BAL and Strengthen U.S. Manufacturing Readiness

January 16, 2026
·
8 min read
Press Releases

Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook

January 16, 2026
·
11 min read